Clinical Trials
6 trialsNCT03498521 2025-11-19
CUPISCO
Hoffmann-La Roche
Phase 2 Completed
NCT05834348 2025-03-30
DELINOR
Pfizer
Completed
NCT04632992 2025-01-08
MyTACTIC
Genentech, Inc.
Phase 2 Completed
NCT04589832 2023-11-22
Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma
Hoosier Cancer Research Network
Phase 1/2 Terminated
NCT03961100 2020-09-07
A Performance and Bioavailability Study of Entrectinib in Healthy Volunteers.
Genentech, Inc.
Phase 1 Completed
NCT02587650 2020-01-27
Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma
University of California, San Francisco
Phase 2 Terminated